(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

DOSAGEM FRACIONADA DE UM ANÁLOGO DE ÉTER FOSFOLIPÍDICO PARA O TRATAMENTO DO CÂNCER

ArquivadaInvention PatentPCT · US2019026828

Application data

Number

112020020758

Type

Invention Patent

Filing

04/10/2019

Publication

01/19/2021

PCT

US2019026828

Progress at the INPI

  1. Filing04/10/19
  2. Publication01/19/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 03/17/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

CELLECTAR BIOSCIENCES, INC.

US

Inventors

J. L. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/655,615 · 04/10/2018

Abstract

DOSAGEM FRACIONADA DE UM ANÁLOGO DE ÉTER FOSFOLIPÍDICO PARA O TRATAMENTO DO CÂNCER. É divulgado aqui um regime de dosagem fracionada de 131I-marcado 18-(p-iodo-fenil)octadecil fosfocolina para o tratamento de câncer

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

03/17/2026

RPI 2880

Parecer de pré-exame

#6.23

12/02/2025

RPI 2865

Adição na publicação

#15.35

12/14/2021

RPI 2658

Alteração de sede deferida

#25.7

08/17/2021

RPI 2641

Notificação de entrada na fase nacional - PCT

#1.3

01/19/2021

RPI 2611

Alteração de dados cadastrais

#1.1

10/20/2020

RPI 2598

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.